Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BridgeBio Pharma, Inc. | President and COO | Common Stock | 396K | $9.66M | $24.40 | Aug 16, 2024 | Direct |
BridgeBio Pharma, Inc. | President and COO | Stock Option (Right to Buy) | 3.16K | Aug 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Aug 16, 2024 | 1 | -$438K | 4 | Aug 20, 2024 | President and COO |
BBIO | BridgeBio Pharma, Inc. | Aug 6, 2024 | 2 | $0 | 4 | Aug 8, 2024 | President and COO |
BBIO | BridgeBio Pharma, Inc. | Jul 23, 2024 | 0 | $0 | 3 | Jul 29, 2024 | President and COO |